Cargando…

Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation

The quality and size of liver grafts are critical factors that influence living‐donor liver transplantation (LDLT) function and safety. However, the biomarkers used for predicting graft quality are lacking. In this study, we sought to identify unique graft quality markers, aside from donor age, by u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomiyama, Takahiro, Yamamoto, Takuya, Takahama, Shokichi, Toshima, Takeo, Itoh, Shinji, Harada, Noboru, Shimokawa, Mototsugu, Okuzaki, Daisuke, Mori, Masaki, Yoshizumi, Tomoharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512467/ https://www.ncbi.nlm.nih.gov/pubmed/35894759 http://dx.doi.org/10.1002/hep4.2033

Ejemplares similares

The authors’ reply: Indispensable discrepancy between predicted graft “volume” and actual graft “weight” in clinical practice in living‐donor liver transplantation
por: Toshima, Takeo, et al.
Publicado: (2021)

Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report
por: Tomiyama, Takahiro, et al.
Publicado: (2021)

Which is better to use “body weight” or “standard liver weight”, for predicting small‐for‐size graft syndrome after living donor liver transplantation?
por: Toshima, Takeo, et al.
Publicado: (2020)

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection
por: Itoh, Shinji, et al.
Publicado: (2022)

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020)

Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
por: Yonemura, Yusuke, et al.
Publicado: (2020)

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature
por: Iseda, Norifumi, et al.
Publicado: (2018)

Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma
por: Shimokawa, Masahiro, et al.
Publicado: (2020)

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2022)

Multiple liver metastases originating from synchronous double cancer of neuroendocrine tumor and rectal cancer: a case report
por: Omori, Sachie, et al.
Publicado: (2020)

Caution for living donor liver transplantation with congenital portosystemic shunt: a case report
por: Nagao, Yoshihiro, et al.
Publicado: (2022)

Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy
por: Inokuchi, Shoichi, et al.
Publicado: (2021)

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2021)

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
por: Iseda, Norifumi, et al.
Publicado: (2021)

Usefulness of microsurgical back‐table angioplasty for multiple hepatic arteries in living donor liver transplantation
por: Harada, Noboru, et al.
Publicado: (2020)

Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
por: Yugawa, Kyohei, et al.
Publicado: (2021)

Retroperitoneal schwannoma preoperatively diagnosed as liver metastasis from colon cancer: A case report
por: Wang, Huanlin, et al.
Publicado: (2019)

Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation
por: Itoh, Shinji, et al.
Publicado: (2021)

Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation
por: Elshawy, Mohamed, et al.
Publicado: (2020)

Correction to: Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation
por: Elshawy, Mohamed, et al.
Publicado: (2020)

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
por: Toshida, Katsuya, et al.
Publicado: (2022)

Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy
por: Yoshizumi, Tomoharu, et al.
Publicado: (2019)

Correction to: Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy
por: Yoshizumi, Tomoharu, et al.
Publicado: (2020)

Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2022)

Living donor liver transplantation indicated for compensated liver cirrhosis with symptomatic gallstone diseases: report of two cases
por: Bekki, Yuki, et al.
Publicado: (2016)

Association between Sarcopenia and Omega-3 Polyunsaturated Fatty Acid in Patients with Hepatocellular Carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

A Multi-Facility, Randomized, Comparative Study Examining the Efficacy of Biliary Reconstruction Under a Surgical Microscope in Living Donor Liver Transplantation
por: Soyama, Akihiko, et al.
Publicado: (2021)

Efficacy of recombinant thrombomodulin for DIC after deceased donor liver transplantation: a case report
por: Kimura, Koichi, et al.
Publicado: (2016)

Elevation of Mac‐2 binding protein glycosylation isomer after hepatectomy is associated with post‐hepatectomy liver failure, total Pringle time, and renal dysfunction
por: Imai, Daisuke, et al.
Publicado: (2019)

Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report
por: Kurihara, Takeshi, et al.
Publicado: (2016)

Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma
por: Toshida, Katsuya, et al.
Publicado: (2022)

Prognostic value and biological function of LRRN4 in colorectal cancer
por: Xu, Cheng, et al.
Publicado: (2022)

Cystic Liver Infection after Living Donor Liver Transplantation: A Case Report
por: Kudou, Kensuke, et al.
Publicado: (2014)

Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Pattern Recognition Receptor Ligands as an Emerging Therapeutic Agent for Latent HIV-1 Infection
por: Takahama, Shokichi, et al.
Publicado: (2020)

LRRN4 and UPK3B Are Markers of Primary Mesothelial Cells
por: Kanamori-Katayama, Mutsumi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2ji0k49gelffhqkus7docvcdib